Actinium Pharmaceuticals reported $1.53M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.63B 54M Jun/2026
Actinium Pharmaceuticals USD 1.53M 1.09M Sep/2025
Amgen USD 1.72B 134M Jun/2026
Bioline Rx USD 858K 257K Mar/2026
Capricor Therapeutics USD 1.92M 446.47K Dec/2025
Pfizer USD 3.41B 496M Jun/2026